Imaging cytokine targeting to the tumor/bone microenvironment in vivo.
Imaging cytokine targeting to the tumor/bone microenvironment in vivo.
复制标题
针对体内肿瘤/骨微环境的细胞因子成像。
DOI:
10.1089/humc.2014.085
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Figueiredo,MarxaL
中科院分区:
文献类型:
--
作者:
Ellis,Jane;Falzon,Miriam;Emrick,Todd;Figueiredo,MarxaL
FIG. 1. Gaussia luciferase modified at the C-terminus with tumor or bone targeting peptides localize to intratibial prostate tumors.(A) Sonodelivery schematic and muscle secretion of tumor-targeted Gluc cytokine model.(B) TC2R-Luc-marked prostate tumor cells implanted in tibia on day 0 give a detectable signal by day 3. Plasmids expressing Gluc (pGL) are delivered intramuscularly (IM) via sonodelivery on day 4, and mice imaged for GLuc expression at day 7 (C).(D) Ex vivo imaging on day 7 shows that only targeted pGluc show signals in tumor/bone metastases.(E) Quantification of fold GLuc signal over control in tumor/bone versus normal organs on day 7 or 18 postsonoporation. In addition,* p< 0.04 compared with normal organs;# p< 0.03 Tu/bone on day 18 compared with Tu/bone signals on day 7. Ctrl refers to delivery of pGL, a plasmid expressing Gaussia luciferase bearing Gluc with a scrambled, nonspecific peptide sequence. Color images available online at www. liebertpub. com/humc